Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Summary by Globe Newswire
Kainova Therapeutics announces a $32M CAD first close of its Series B financing, led by Investissement Québec with participation from existing investors....

9 Articles

Globe NewswireGlobe Newswire
+8 Reposted by 8 other sources
Center

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Kainova Therapeutics announces a $32M CAD first close of its Series B financing, led by Investissement Québec with participation from existing investors....

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources lean Left
75% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Record broke the news in Waterloo, Canada on Tuesday, February 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

St. Catharines icon

St. Catharines

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal